CNTX-6970

N/A

Report date: 2022/05/07 13:38:33
NME

Base Information

Drug NameCNTX-6970
Drug Alias NameCNTX-6970
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsNociceptive PainChronic PainOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesMassachusetts General Hospital
Inactive CompaniesCentrexion Therapeutics Corp
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsNociceptive PainChronic Pain

Other Information

ATC CodeN/A
Related LinksN/A